Back to search
FDAFDA · Food and drugs·Recall number Z-1393-2023

JOURNEY II UNI XLPE TIBIA INSERT MEDIAL SZ 7-8 8MM

Published April 26, 2023 · Recall initiated: March 27, 2023

Summary

FDA records medical device Class II recall Z-1393-2023, published April 26, 2023 and initiated March 27, 2023. Recalling firm: Smith & Nephew, Inc.; Status: Ongoing; Reported quantity: 12 units; Lot: Catalog Number: 74026178; UDI/DI: 00885556677209; Batch Number: 22CAP0038R; Lot Number: 22CAP0038R. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A mispack occurred during the manufacturing process, resulting in the box incorrectly containing JOURNEY II UNI Tibia Insert Medical Size 1-2 12MM instead of the JOURNEY II UNI Tibia Insert Medial Size 7-8 8MM.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Smith & Nephew, Inc.
Distributor
US Nationwide distribution in the states of IL, MD, MI, MS, NY, OH, TX, VA, WA.
Lot
Catalog Number: 74026178; UDI/DI: 00885556677209; Batch Number: 22CAP0038R; Lot Number: 22CAP0038R
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was JOURNEY II UNI XLPE TIBIA INSERT MEDIAL SZ 7-8 8MM recalled?

Yes. FDA published recall Z-1393-2023 on April 26, 2023. Reported hazard: A mispack occurred during the manufacturing process, resulting in the box incorrectly containing JOURNEY II UNI Tibia Insert Medical Size 1-2 12MM instead of the JOURNEY II UNI Tibia Insert Medial Size 7-8 8MM.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit